In a world where the quest for eternal youth seems to be never-ending, a new wave of scientific breakthroughs is changing the way we perceive ageing. From targeting specific genes to experimenting with existing drugs, researchers are on the brink of a major shift in the field of geroscience.
The Editor of the FT, Roula Khalaf, highlights the latest developments in the science of ageing in her weekly newsletter. With the goal of improving the final decade of life for everyone, regardless of social status, the focus is on maintaining vitality and health as we age.
One of the key players in this emerging field is Cynthia Kenyon, a biologist who discovered that disabling a single gene could double the lifespan of roundworms. This groundbreaking research has paved the way for further studies on targeting the biology of ageing itself.
From experiments with rapamycin to trials with metformin, researchers are exploring new avenues to delay the onset of age-related diseases. The Dog Aging Project, which aims to extend the longevity and health of pets through clinical trials, is also shedding light on potential treatments for humans.
While the idea of extending lifespan may seem self-indulgent in the face of global health crises, the possibility of compressing morbidity and enjoying a healthier, more active old age is a liberating thought. As researchers continue to push the boundaries of science, the future of ageing looks brighter than ever before.